Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$3.19 +0.04 (+1.27%)
At close: Aug 20, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Debt Ratio (2023 - 2026)

Acumen Pharmaceuticals (ABOS) posted Debt Ratio of 0.23 for Q1 2026, down 8.42% sequentially from 0.25 in Q4 2025, and up 60.89% YoY from 0.14 in Q1 2025.

Acumen Pharmaceuticals (ABOS) Debt Ratio (2023 - 2026) Analysis & Trends

Acumen Pharmaceuticals has reported Debt Ratio for 4 years, with the latest figure at 0.23 in Q1 2026.

  • Quarterly Debt Ratio rose 60.89% year-over-year to 0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.23 (up 60.89% YoY) and the FY2025 annual result came in at 0.25, up 106.09% from the prior year.
  • Debt Ratio slipped to 0.23 in Q1 2026 per ABOS's latest filing, from 0.25 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.25 in Q4 2025 and troughed at 0.1 in Q4 2023.
  • A 4-year average of 0.16 and a median of 0.13 in 2024 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2024 and 2025: Debt Ratio increased 27.69% in 2024, then surged 106.09% in 2025.
  • Over 4 years, Debt Ratio stood at 0.1 in 2023, then gained by 27.69% to 0.12 in 2024, then jumped by 106.09% to 0.25 in 2025, then fell by 8.42% to 0.23 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.23, 0.25, and 0.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.05
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.26
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.47
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.03
10 Acumen Pharmaceuticals 229.03 Mn 229.03 Mn - 0.27

Historic Data

Download Data
DateValue
Jun 30, 2026 0.27
Mar 31, 2026 0.23
Dec 31, 2025 0.25
Sep 30, 2025 0.22
Jun 30, 2025 0.17
Mar 31, 2025 0.14
Dec 31, 2024 0.12
Sep 30, 2024 0.11
Jun 30, 2024 0.10
Mar 31, 2024 0.10
Dec 31, 2023 0.10